{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,19]],"date-time":"2026-09-19T19:56:08Z","timestamp":1789847768120,"version":"4.0.1"},"reference-count":30,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2014,8,1]],"date-time":"2014-08-01T00:00:00Z","timestamp":1406851200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Medicinal Chemistry"],"published-print":{"date-parts":[[2014,8]]},"DOI":"10.1016\/j.ejmech.2014.06.051","type":"journal-article","created":{"date-parts":[[2014,6,25]],"date-time":"2014-06-25T07:46:58Z","timestamp":1403682418000},"page":"433-447","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":42,"special_numbering":"C","title":["Cationic lipid-conjugated dexamethasone as a selective antitumor agent"],"prefix":"10.1016","volume":"83","author":[{"given":"Samaresh","family":"Sau","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rajkumar","family":"Banerjee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejmech.2014.06.051_bib1","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1146\/annurev.immunol.18.1.309","article-title":"Glucocorticoids in T cell development and function","volume":"18","author":"Ashwell","year":"2000","journal-title":"Annu. Rev. Immunol."},{"key":"10.1016\/j.ejmech.2014.06.051_bib2","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S1054-3589(08)60108-8","article-title":"New insights into glucocorticoid and mineralocorticoid signaling: lessons from gene targeting","volume":"47","author":"Reichardt","year":"2000","journal-title":"Adv. Pharmacol."},{"key":"10.1016\/j.ejmech.2014.06.051_bib3","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1110\/ps.051781406","article-title":"Conformational changes of the glucocorticoid receptor ligand binding domain induced by ligand and cofactor binding, and the location of cofactor binding sites determined by hydrogen\/deuterium exchange mass spectrometry","volume":"15","author":"Frego","year":"2006","journal-title":"Protein Sci."},{"key":"10.1016\/j.ejmech.2014.06.051_bib4","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1038\/ncpendmet0745","article-title":"Drug insight: selective agonists and antagonists of the glucocorticoid receptor","volume":"4","author":"McMaster","year":"2008","journal-title":"Nat. Clin. Pract. Endocrinol. Metab."},{"key":"10.1016\/j.ejmech.2014.06.051_bib5","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1016\/0092-8674(95)90201-5","article-title":"Steroid hormone receptors: many actors in search of a plot","volume":"83","author":"Beato","year":"1995","journal-title":"Cell"},{"key":"10.1016\/j.ejmech.2014.06.051_bib6","first-page":"1214","article-title":"Mutation of isoleucine 747 by a threonine alters the ligand responsiveness of the human glucocorticoid receptor","volume":"10","author":"Roux","year":"1996","journal-title":"Mol. Endocrinol."},{"key":"10.1016\/j.ejmech.2014.06.051_bib7","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s004180000165","article-title":"The molecular basis of glucocorticoid-induced apoptosis of lymphoblastic leukemia cells","volume":"114","author":"Kofler","year":"2000","journal-title":"Histochem. Cell Biol."},{"key":"10.1016\/j.ejmech.2014.06.051_bib8","doi-asserted-by":"crossref","first-page":"1338","DOI":"10.1182\/blood-2007-11-124156","article-title":"Dexamethasone-induced apoptotic mechanisms in myeloma cells investigated by analysis of mutant glucocorticoid receptors","volume":"112","author":"Sharma","year":"2008","journal-title":"Blood"},{"key":"10.1016\/j.ejmech.2014.06.051_bib9","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1007\/s00520-011-1312-8","article-title":"Aprepitant, dexamethasone, and palonosetron in the prevention of doxorubicin\/cyclophosphamide-induced nausea and vomiting","volume":"20","author":"Hesketh","year":"2012","journal-title":"Support Care Cancer"},{"key":"10.1016\/j.ejmech.2014.06.051_bib10","first-page":"1139","article-title":"Dexamethasone treatment inhibits VEGF production via suppression of STAT3 in a head and neck cancer cell line","volume":"23","author":"Shim","year":"2010","journal-title":"Oncol. Rep."},{"key":"10.1016\/j.ejmech.2014.06.051_bib11","doi-asserted-by":"crossref","first-page":"e51821","DOI":"10.1371\/journal.pone.0051821","article-title":"Dexamethasone reduces sensitivity to cisplatin by blunting p53-dependent cellular senescence in non-small cell lung cancer","volume":"7","author":"Ge","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.ejmech.2014.06.051_bib12","first-page":"3112","article-title":"Glucocorticoid cotreatment induces apoptosis resistance toward cancer therapy in carcinomas","volume":"63","author":"Herr","year":"2003","journal-title":"Cancer Res."},{"key":"10.1016\/j.ejmech.2014.06.051_bib13","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1038\/mt.2009.4","article-title":"Selective cancer targeting via aberrant behavior of cancer cell-associated glucocorticoid receptor","volume":"17","author":"Mukherjee","year":"2009","journal-title":"Mol. Ther."},{"key":"10.1016\/j.ejmech.2014.06.051_bib14","doi-asserted-by":"crossref","first-page":"2378","DOI":"10.1021\/jm101530j","article-title":"Structure-activity study to develop cationic lipid-conjugated haloperidol derivatives as a new class of anticancer therapeutics","volume":"54","author":"Pal","year":"2011","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2014.06.051_bib15","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1158\/1541-7786.MCR-10-0526","article-title":"A\u00a0lipid-modified estrogen derivative that treats breast cancer independent of estrogen receptor expression through simultaneous induction of autophagy and apoptosis","volume":"9","author":"Sinha","year":"2011","journal-title":"Mol. Cancer Res."},{"key":"10.1016\/j.ejmech.2014.06.051_bib16","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1016\/j.ejmech.2012.07.035","article-title":"Anticancer siRNA delivery by new anticancer molecule: a novel combination strategy for cancer cell killing","volume":"56","author":"Muktapurama","year":"2012","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2014.06.051_bib17","doi-asserted-by":"crossref","first-page":"4247","DOI":"10.1021\/ja9941532","article-title":"Dexamethasone\u2013methotrexate:\u2009 an efficient chemical inducer of protein dimerization in\u00a0vivo","volume":"122","author":"Lin","year":"2000","journal-title":"J.\u00a0Am. Chem. Soc."},{"key":"10.1016\/j.ejmech.2014.06.051_bib18","doi-asserted-by":"crossref","first-page":"114","DOI":"10.2174\/13894501113149990194","article-title":"MDM2-p53 interaction in paediatric solid tumours: preclinical rationale, biomarkers and resistance","volume":"15","author":"Giuseppe","year":"2014","journal-title":"Curr. Drug Targets"},{"key":"10.1016\/j.ejmech.2014.06.051_bib19","doi-asserted-by":"crossref","first-page":"e47516","DOI":"10.1371\/journal.pone.0047516","article-title":"Quercetin inhibits angiogenesis mediated human prostate tumor growth by targeting VEGFR-2 regulated AKT\/mTOR\/P70S6K signaling pathways","volume":"7","author":"Pratheeshkumar","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.ejmech.2014.06.051_bib20","doi-asserted-by":"crossref","unstructured":"S. Saeed, B.D. Mohammad, M. Gholamreza, T. Mohammadreza, Role of Caspases, Bax and Bcl-2 in chrysin-induced apoptosis in the A549 human lung adenocarcinoma epithelial cells, Anti Cancer Agents Med. Chem. http:\/\/dx.doi.org\/10.2174\/1871520614666140209144042.","DOI":"10.2174\/1871520614666140209144042"},{"key":"10.1016\/j.ejmech.2014.06.051_bib21","doi-asserted-by":"crossref","first-page":"1966","DOI":"10.1126\/science.278.5345.1966","article-title":"Conversion of Bcl-2 to a Bax-like death effector by caspases","volume":"278","author":"Cheng","year":"1997","journal-title":"Science"},{"key":"10.1016\/j.ejmech.2014.06.051_bib22","doi-asserted-by":"crossref","first-page":"30718","DOI":"10.1074\/jbc.M705258200","article-title":"Dimeric Smac\/Diablo peptide directly relieves caspase-3 inhibition by XIAP dynamic and cooperative regulation of XIAP by Smac\/Diablo","volume":"282","author":"Gao","year":"2007","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.ejmech.2014.06.051_bib23","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1016\/j.mito.2010.08.003","article-title":"Multistep and multitask Bax activation","volume":"10","author":"Ghibelli","year":"2010","journal-title":"Mitochondrion"},{"key":"10.1016\/j.ejmech.2014.06.051_bib24","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1006\/excr.1999.4690","article-title":"The regulation and activities of the multifunctional serine\/threonine kinase Akt\/PKB","volume":"253","author":"Kandel","year":"1999","journal-title":"Exp. Cell Res."},{"key":"10.1016\/j.ejmech.2014.06.051_bib25","doi-asserted-by":"crossref","first-page":"10983","DOI":"10.1073\/pnas.211430998","article-title":"Akt plays a central role in tumorigenesis","volume":"98","author":"Testa","year":"2001","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.ejmech.2014.06.051_bib26","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1158\/1535-7163.MCT-06-0561","article-title":"Deactivation of Akt and STAT3 signaling promotes apoptosis, inhibits proliferation, and enhances the sensitivity of hepatocellular carcinoma cells to an anticancer agent, Atiprimod","volume":"6","author":"Choudhari","year":"2007","journal-title":"Mol. Cancer Ther."},{"key":"10.1016\/j.ejmech.2014.06.051_bib27","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1016\/S0092-8674(00)81871-1","article-title":"p53 the cellular gate keeper for growth and division","volume":"88","author":"Levine","year":"1997","journal-title":"Cell"},{"key":"10.1016\/j.ejmech.2014.06.051_bib28","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1038\/351453a0","article-title":"The p53 tumour suppressor gene","volume":"351","author":"Levine","year":"1991","journal-title":"Nature"},{"key":"10.1016\/j.ejmech.2014.06.051_bib29","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1016\/j.biomaterials.2012.05.006","article-title":"A\u00a0long-lasting dendritic cell DNA vaccination system using lysinylated amphiphiles with mannose-mimicking head-groups","volume":"33","author":"Srinivas","year":"2012","journal-title":"Biomaterials"},{"key":"10.1016\/j.ejmech.2014.06.051_bib30","doi-asserted-by":"crossref","first-page":"6804","DOI":"10.1016\/j.biomaterials.2013.05.054","article-title":"Hsp90-targeted miRNA-liposomal formulation for systemic antitumor effect","volume":"34","author":"Pore","year":"2013","journal-title":"Biomaterials"}],"container-title":["European Journal of Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523414005807?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523414005807?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,8,21]],"date-time":"2020-08-21T09:53:58Z","timestamp":1598003638000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0223523414005807"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,8]]},"references-count":30,"alternative-id":["S0223523414005807"],"URL":"https:\/\/doi.org\/10.1016\/j.ejmech.2014.06.051","relation":{},"ISSN":["0223-5234"],"issn-type":[{"value":"0223-5234","type":"print"}],"subject":[],"published":{"date-parts":[[2014,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Cationic lipid-conjugated dexamethasone as a selective antitumor agent","name":"articletitle","label":"Article Title"},{"value":"European Journal of Medicinal Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejmech.2014.06.051","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}]}}